1. Home
  2. HNI vs IMNM Comparison

HNI vs IMNM Comparison

Compare HNI & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HNI Corporation

HNI

HNI Corporation

HOLD

Current Price

$32.44

Market Cap

2.5B

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$21.85

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HNI
IMNM
Founded
1944
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.8B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
HNI
IMNM
Price
$32.44
$21.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
10
Target Price
$70.00
$32.80
AVG Volume (30 Days)
805.0K
1.2M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
4.07%
N/A
EPS Growth
N/A
51.40
EPS
1.11
N/A
Revenue
$2,839,000,000.00
$6,941,000.00
Revenue This Year
$117.47
N/A
Revenue Next Year
$3.55
$1,127.34
P/E Ratio
$30.11
N/A
Revenue Growth
12.37
N/A
52 Week Low
$32.59
$5.15
52 Week High
$53.29
$27.65

Technical Indicators

Market Signals
Indicator
HNI
IMNM
Relative Strength Index (RSI) 24.27 53.87
Support Level N/A $19.26
Resistance Level $47.68 $22.57
Average True Range (ATR) 1.44 1.06
MACD -0.12 0.26
Stochastic Oscillator 4.56 67.21

Price Performance

Historical Comparison
HNI
IMNM

About HNI HNI Corporation

HNI Corp is a provider of commercial furnishings and hearth products. Its two reportable segments are workplace furnishings and residential building products. The workplace furnishings segment includes furniture systems, seating, storage, tables, architectural products, ancillary products, and hospitality products. The residential building products segment includes various gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, outdoor fire pits and fire tables, and accessories. The company's products are sold through independent dealers, distributors, eCommerce retailers, wholesalers, and retail outlets. A majority of the firm's revenue is generated from the Workplace furnishings segment. Geographically, it operates in the United States.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: